142 related articles for article (PubMed ID: 16187973)
1. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
[TBL] [Abstract][Full Text] [Related]
2. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study.
Metra M; Zani C; Covolo L; Nodari S; Pezzali N; Gelatti U; Donato F; Nardi G; Dei Cas L
Eur J Heart Fail; 2006 Mar; 8(2):131-5. PubMed ID: 16188498
[TBL] [Abstract][Full Text] [Related]
3. The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.
Du Preez J; Matolweni LO; Greenberg J; Mntla P; Adeyemo AA; Mayosi BM
Cardiovasc J Afr; 2008; 19(1):15-6. PubMed ID: 18320080
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
[TBL] [Abstract][Full Text] [Related]
5. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
7. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.
Small KM; Wagoner LE; Levin AM; Kardia SL; Liggett SB
N Engl J Med; 2002 Oct; 347(15):1135-42. PubMed ID: 12374873
[TBL] [Abstract][Full Text] [Related]
8. Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.
Woodiwiss AJ; Badenhorst D; Sliwa K; Brooksbank R; Essop R; Sareli P; Norton GR
Cardiovasc J Afr; 2008; 19(4):188-93. PubMed ID: 18776959
[TBL] [Abstract][Full Text] [Related]
9. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
[TBL] [Abstract][Full Text] [Related]
11. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
[TBL] [Abstract][Full Text] [Related]
13. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
14. Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume.
Canham RM; Das SR; Leonard D; Abdullah SM; Mehta SK; Chung AK; Li JL; Victor RG; Auchus RJ; Drazner MH
J Am Coll Cardiol; 2007 Jan; 49(2):274-6. PubMed ID: 17222742
[No Abstract] [Full Text] [Related]
15. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.
Iwai C; Akita H; Shiga N; Takai E; Miyamoto Y; Shimizu M; Kawai H; Takarada A; Kajiya T; Yokoyama M
Circ J; 2002 Aug; 66(8):723-8. PubMed ID: 12197595
[TBL] [Abstract][Full Text] [Related]
16. Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy.
Amar J; Brunel J; Cardot Bauters C; Jacques V; Delmas C; Odou MF; Savagner F
Endocr Relat Cancer; 2022 Apr; 29(5):267-272. PubMed ID: 35258481
[TBL] [Abstract][Full Text] [Related]
17. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
[TBL] [Abstract][Full Text] [Related]
18. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
20. Impact of synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy.
Ogimoto A; Okayama H; Nagai T; Suzuki J; Inoue K; Nishimura K; Shigematsu Y; Tabara Y; Miki T; Higaki J
Circ J; 2012; 76(8):2003-8. PubMed ID: 22664639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
